Zhejiang Huakang Pharmaceutical Co., Ltd. (SHA:605077)
China · Delayed Price · Currency is CNY 10.14
-0.03 (-0.29%)
Nov 13, 2026, 9:30 AM CST
SHA:605077 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1,547 | 1,159 | 434.21 | 2,128 | 1,040 | 1,244 |
Short-Term Investments | - | 554.39 | 583.66 | 461.79 | 387.5 | - |
Trading Asset Securities | 93.02 | 200 | 0.03 | 0.18 | 0.22 | 70.05 |
Cash & Short-Term Investments | 1,640 | 1,913 | 1,018 | 2,590 | 1,428 | 1,314 |
Cash Growth | 36.45% | 87.95% | -60.70% | 81.38% | 8.72% | 427.99% |
Accounts Receivable | 787.17 | 694.07 | 769.01 | 500.31 | 392.94 | 242.55 |
Other Receivables | 23.11 | 15.27 | 26.7 | 6.05 | 8.14 | 14.58 |
Receivables | 810.27 | 709.34 | 795.71 | 506.37 | 401.08 | 257.13 |
Inventory | 882.54 | 768.73 | 697.39 | 282.04 | 279.06 | 199.74 |
Other Current Assets | 383.23 | 25.17 | 64.21 | 36.16 | 29.87 | 32.23 |
Total Current Assets | 3,716 | 3,416 | 2,575 | 3,415 | 2,138 | 1,803 |
Property, Plant & Equipment | 3,856 | 3,801 | 3,588 | 1,844 | 1,355 | 991.3 |
Long-Term Investments | 64.84 | 73.7 | 93.49 | 94.42 | 122.53 | 58.56 |
Goodwill | 346.16 | 346.16 | 346.16 | 346.16 | 26.11 | 26.11 |
Other Intangible Assets | 291.39 | 297.78 | 305.87 | 282.65 | 242.46 | 90.06 |
Long-Term Deferred Tax Assets | 51.97 | 35.78 | 23.53 | 8.13 | 3.95 | 7.37 |
Long-Term Deferred Charges | 24.09 | 33.03 | 35.13 | 17.29 | 11.14 | 12.54 |
Other Long-Term Assets | 113.66 | 36.33 | 24.89 | 169.79 | 5.62 | 15.4 |
Total Assets | 8,464 | 8,040 | 6,992 | 6,178 | 3,905 | 3,004 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1,098 | 645.28 | 443.34 | 208.42 | 169.9 | 228.07 |
Accrued Expenses | 45.97 | 157.46 | 122.64 | 88.55 | 71.24 | 41.37 |
Short-Term Debt | 1,082 | 704.11 | 150.3 | 247.12 | 260.24 | 119.82 |
Current Portion of Long-Term Debt | 363.35 | 306.82 | 226.64 | 171.65 | 39.74 | - |
Current Portion of Leases | - | 3.38 | 0.95 | 0.56 | 1.24 | - |
Current Income Taxes Payable | 28.11 | 23.93 | 37.1 | 32.34 | - | - |
Current Unearned Revenue | 26.31 | 28.82 | 15.01 | 19.95 | 12.05 | 8.58 |
Other Current Liabilities | 112.53 | 564.07 | 677.18 | 253.16 | 215.12 | 57.88 |
Total Current Liabilities | 2,757 | 2,434 | 1,673 | 1,022 | 769.53 | 455.72 |
Long-Term Debt | 2,266 | 2,110 | 1,859 | 1,868 | 345.46 | 20.02 |
Long-Term Leases | 12.08 | 7.06 | 3.2 | 0.02 | 0.51 | 1.46 |
Long-Term Unearned Revenue | 155.83 | 160.08 | 118.28 | 94.21 | 51.37 | 38.4 |
Long-Term Deferred Tax Liabilities | 64.82 | 74.14 | 82.62 | 92.19 | 74.37 | 53.95 |
Other Long-Term Liabilities | - | - | - | - | 8 | - |
Total Liabilities | 5,256 | 4,785 | 3,737 | 3,077 | 1,249 | 569.56 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 302.7 | 303.05 | 305.88 | 234.61 | 228.46 | 163.18 |
Additional Paid-In Capital | 1,412 | 1,427 | 1,441 | 1,479 | 1,405 | 1,470 |
Retained Earnings | 1,322 | 1,351 | 1,363 | 1,257 | 1,023 | 801.28 |
Treasury Stock | -28.97 | -36.1 | -61.99 | -77.37 | - | - |
Comprehensive Income & Other | 196.1 | 196.07 | 196.13 | 196.23 | -0.01 | -0.02 |
Total Common Equity | 3,203 | 3,240 | 3,243 | 3,089 | 2,656 | 2,434 |
Minority Interest | 4.41 | 14.3 | 11.89 | 11.59 | - | - |
Shareholders' Equity | 3,208 | 3,255 | 3,255 | 3,101 | 2,656 | 2,434 |
Total Liabilities & Equity | 8,464 | 8,040 | 6,992 | 6,178 | 3,905 | 3,004 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 3,724 | 3,131 | 2,241 | 2,288 | 647.18 | 141.3 |
Net Cash (Debt) | -2,084 | -1,218 | -1,223 | 302.51 | 780.96 | 1,172 |
Net Cash Growth | - | - | - | -61.26% | -33.38% | 1135.67% |
Net Cash Per Share | -6.89 | -4.01 | -3.23 | 1.02 | 2.63 | 4.08 |
Filing Date Shares Outstanding | 283.37 | 299.43 | 299.43 | 296.99 | 296.99 | 296.99 |
Total Common Shares Outstanding | 283.37 | 299.43 | 299.43 | 296.99 | 296.99 | 296.99 |
Working Capital | 959.19 | 982.54 | 902.05 | 2,393 | 1,369 | 1,347 |
Book Value Per Share | 10.61 | 10.17 | 10.18 | 9.74 | 8.94 | 8.20 |
Tangible Book Value | 2,566 | 2,597 | 2,591 | 2,461 | 2,387 | 2,318 |
Tangible Book Value Per Share | 8.36 | 8.02 | 8.00 | 7.62 | 8.04 | 7.81 |
Buildings | - | 1,379 | 1,014 | 576.89 | 429.74 | 336.07 |
Machinery | - | 3,418 | 2,262 | 1,803 | 1,429 | 960.55 |
Construction In Progress | - | 284.29 | 1,330 | 290.58 | 110.27 | 230.98 |